Early detection of airway disease is an important public health priority with an urgent need for simple diagnostic tools that are easier to deploy than traditional spirometry.
Eupnoos, an innovative health tech company, has created an audio phenotyping platform capable of detecting spectral patterns in breath sounds recorded using the MEMS microphone on a smartphone. Their advanced algorithms can identify and quantify distinct features in these sounds, potentially enabling early diagnosis of respiratory conditions.
Eupnoos recently won the «Reto Platón,» an initiative by AstraZeneca Spain and Kunsen, which supports projects that enhance the diagnosis and management of symptoms in oncology patients. This victory underscores Eupnoos’ potential in transforming early detection and monitoring of interstitial lung diseases (ILDs), severe side effects associated with certain cancer treatments.
The Reto Platón challenge, initiated by the Platón Group of young oncologists during the 2024 FYFN event at the Mobile World Congress, attracted 34 project submissions. Among these, six teams were shortlisted to present their innovations to a panel of medical experts from AstraZeneca Spain and Kunsen.
The company will receive support from AstraZeneca Spain, including a €5,000 grant, brand recognition, and communication support. AstraZeneca Spain has also committed to exploring potential funding and development partnerships for Eupnoos’ project within the healthcare system.
Article written by Corresponsables| Image by Eupnoos
11/07/2024
Source:
Corresponsables
https://www.corresponsables.com/actualidad/social/el-software-de-eupnoos-para-analizar-la-respiracion-de-pacientes-oncologicos-gana-el-reto-platon-impulsado-por-astrazeneca-espana-y-kunsen/